TARDBP and amyotrophic lateral sclerosis: The question of whether the pathological effects of TDP-43 in ALS and FTLD-TDP are caused by a nuclear loss of function or a cytoplasmic gain of function is still uncertain [44], but this study provides an improved understanding of the effects of a cytoplasmic gain of function.